Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Detection of Stomach Cancer With a Liquid Biopsy Based on Exosomal Micro-RNA

NCT06342427 is registered in ClinicalTrials.gov with City of Hope Medical Center as lead sponsor.

NCT NCT06342427
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06342427 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Detection of Stomach Cancer With a Liquid Biopsy Based on Exosomal Micro-RNA
Lead sponsor
City of Hope Medical Center
Phase
Observational
Overall status
Completed
Start date
March 15, 2023
Completion date
June 15, 2024
Enrollment
809 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

gastric adenocarcinoma, gastric cancer, gastric cancer in situ, gastric cancer metastatic to liver, gastric cancer metastatic to lung, gastric cancer stage, gastric cancer stage i, gastric cancer stage ia, gastric cancer stage ib, gastric cancer stage ii, gastric cancer stage iii, gastric cancer stage iiia, gastric cancer stage iiib, gastric cancer stage iv, gastric cancer tnm staging, gastric cancer tnm staging primary tumor (t) t2b, gastric cancer, stage 0, gastric lesion, gastric neoplasm